Rachel M. Pearce - Concepedia

Concepedia

Author

Rachel M. Pearce

University College London

Also Known As

R M Pearce, R. M. Pearce, R.M. Pearce, Rachel M Pearce, Rachel M. Pearce

32

Publications

1.4K

Citations

16

H-Index

46

Concepts

All Affiliations

University College London University of Washington Royal Marsden Hospital Guy's Hospital The Royal Free Hospital

RM

About

Rachel M. Pearce is an author at University College London specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	690
2	Health Sciences	5	5	266
3	Blood Transplantation	5	5	181
4	Public Health	3	3	103
5	Cellular Therapies	2	2	124

Rachel M. Pearce

×

20

Publications

1.4K

Citations

16

H-Index

	Year	Citations
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. Nöel Milpied, Adele K. Fielding, Rachel M. Pearce, Journal of Clinical Oncology	1996	226
Cell Membrane <i>Trans</i> -Fatty Acids and the Risk of Primary Cardiac Arrest Rozenn N. Lemaître, Irena B. King, Trivellore E. Raghunathan, Circulation	2002	220
Incidence of Out-of-Hospital cardiac arrest Thomas D. Rea, Rachel M. Pearce, Trivellore E. Raghunathan, The American Journal of Cardiology Cardiopulmonary ResuscitationCardiovascular DiseaseMedicinePatient SafetyOut-of-hospital Cardiac Arrest	2004	176
Genetic Variants of Platelet Glycoprotein Receptors and Risk of Stroke in Young Women Alexander P. Reiner, Prasanna N. Kumar, Stephen M. Schwartz, Stroke	2000	127
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant Bronwen E. Shaw, G J Mufti, Stephen Mackinnon, Bone Marrow Transplantation Transplant RejectionTransplantationReduced-intensity ConditioningMedicineSecond Allogeneic Transplants	2008	111
Outcome of Donor Lymphocyte Infusion after T Cell–depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes Pramila Krishnamurthy, Victoria Potter, Linda D. Barber, Biology of Blood and Marrow Transplantation Cell TherapyTcd Ric HsctImmunologyImmunotherapyAcute Myelogenous Leukemia	2012	89
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation Judith Marsh, Rachel M. Pearce, Mickey Koh, Bone Marrow Transplantation Retrospective StudyTransplantationMarrow TransplantationHematologySevere Aplastic Anemia	2013	85
Electrocardiographic QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients Eric A. Whitsel, Edward J. Boyko, Pentti M. Rautaharju, Diabetes Care HypertensionHeart FailureCardiometabolic RiskDiabetic PatientsPuget Sound	2005	57
Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest Rozenn N. Lemaître, David S. Siscovick, Bruce M. Psaty, The American Journal of Medicine Primary Cardiac ArrestBeta-adrenergic PharmacologyPulmonary Pharmacology	2002	47
Haematopoietic stem cell transplantation (<scp>HSCT</scp>) in severe autoimmune diseases: analysis of <scp>UK</scp> outcomes from the British Society of Blood and Marrow Transplantation (<scp>BSBMT</scp>) data registry 1997–2009 John A. Snowden, Rachel M. Pearce, Julia Lee, British Journal of Haematology	2012	38

Page 1